Cheng B |
Advances in prevention and treatment of MAC. |
1995 |
PI Perspect |
pmid:11363104
|
Bermudez LE et al. |
Efficacy of azithromycin and rifabutin in preventing infection by Mycobacterium avium complex in beige mice. |
1995 |
J. Antimicrob. Chemother. |
pmid:8591938
|
Domingo S et al. |
Comparative activity of azithromycin and doxycycline against Brucella spp. infection in mice. |
1995 |
J. Antimicrob. Chemother. |
pmid:8591939
|
Nash KA and Inderlied CB |
Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease. |
1995 |
Antimicrob. Agents Chemother. |
pmid:8592991
|
Bohte R et al. |
Levels of azithromycin and alpha-1 acid glycoprotein in serum in patients with community-acquired pneumonia. |
1995 |
Antimicrob. Agents Chemother. |
pmid:8593024
|
Tribble D et al. |
Efficacy of azithromycin for typhoid fever. |
1995 |
Clin. Infect. Dis. |
pmid:8645805
|
Strickman D et al. |
In vitro effectiveness of azithromycin against doxycycline-resistant and -susceptible strains of Rickettsia tsutsugamushi, etiologic agent of scrub typhus. |
1995 |
Antimicrob. Agents Chemother. |
pmid:8585717
|
Kuzman I et al. |
Azithromycin for treatment of community acquired pneumonia caused by Legionella pneumophila: a retrospective study. |
1995 |
Scand. J. Infect. Dis. |
pmid:8588143
|
Principi N |
Multicentre comparative study of the efficacy and safety of azithromycin compared with amoxicillin/clavulanic acid in the treatment of paediatric patients with otitis media. |
1995 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:8565983
|
Gill CJ et al. |
In vivo evaluation of three acid-stable azalide compounds, L-701,677, L-708,299 and L-708,365 compared to erythromycin, azithromycin and clarithromycin. |
1995 |
J. Antibiot. |
pmid:7490222
|
Silvestri M et al. |
Azithromycin induces in vitro a time-dependent increase in the intracellular killing of Staphylococcus aureus by human polymorphonuclear leucocytes without damaging phagocytes. |
1995 |
J. Antimicrob. Chemother. |
pmid:8821593
|
Patton DL et al. |
The activity of azithromycin on the infectivity of Chlamydia trachomatis in human amniotic cells. |
1995 |
J. Antimicrob. Chemother. |
pmid:8821594
|
Spangler SK et al. |
Susceptibilities of 201 anaerobes to erythromycin, azithromycin, clarithromycin, and roxithromycin by oxyrase agar dilution and E test methodologies. |
1995 |
J. Clin. Microbiol. |
pmid:7615756
|
Ramadan MA et al. |
Post-antibiotic effect of azithromycin and erythromycin on streptococcal susceptibility to phagocytosis. |
1995 |
J. Med. Microbiol. |
pmid:7752216
|
Martin DH et al. |
Comparison of azithromycin and ceftriaxone for the treatment of chancroid. |
1995 |
Clin. Infect. Dis. |
pmid:8562752
|
Kieserman SP et al. |
Streptococcal pharyngitis: alternative treatments. |
1995 |
Ear Nose Throat J |
pmid:8536567
|
van Rijsoort-Vos JH et al. |
In-vitro activity of a new quinolone (CP-99,219) compared with ciprofloxacin, pefloxacin, azithromycin and penicillin against Neisseria gonorrhoeae. |
1995 |
J. Antimicrob. Chemother. |
pmid:8537268
|
Carbon C |
[Azithromycin: from macrolides to azalides]. |
1995 |
Pathol. Biol. |
pmid:8539067
|
|
[Special issue devoted to azithromycin]. |
1995 |
Pathol. Biol. |
pmid:8539068
|
Tissi L et al. |
In vivo efficacy of azithromycin in treatment of systemic infection and septic arthritis induced by type IV group B Streptococcus strains in mice: comparative study with erythromycin and penicillin G. |
1995 |
Antimicrob. Agents Chemother. |
pmid:8540695
|
Bergogne-Bérézin E |
[Azithromycin: tissue pharmacology]. |
1995 |
Pathol. Biol. |
pmid:8539071
|
Singlas E |
[Clinical pharmacokinetics of azithromycin]. |
1995 |
Pathol. Biol. |
pmid:8539072
|
Felstead S |
Azithromycin drug interactions. |
1995 |
Pathol. Biol. |
pmid:8539073
|
Modaï J |
[Azithromycin: clinical assessment]. |
1995 |
Pathol. Biol. |
pmid:8539076
|
Gehanno P |
[Use of azithromycin in ORL]. |
1995 |
Pathol. Biol. |
pmid:8539077
|
Leophonte P |
[Azithromycin and bronchopulmonary infections]. |
1995 |
Pathol. Biol. |
pmid:8539078
|
Tajima T et al. |
[Pharmacokinetic and clinical studies with azithromycin (fine granule) in the pediatric field. Pediatric Study Group of Azithromycin]. |
1995 |
Jpn J Antibiot |
pmid:7474329
|
Fujii R et al. |
[Pharmacokinetic and clinical studies with azithromycin (capsule) in the pediatric field. Pediatric Study Group of Azithromycin]. |
1995 |
Jpn J Antibiot |
pmid:7474330
|
Sasaki J et al. |
[Comparative clinical study of azithromycin with tosufloxacin tosilate in the treatment of acute odontogenic infection]. |
1995 |
Jpn J Antibiot |
pmid:7474331
|
Uchino U et al. |
[Effects of azithromycin on fecal flora of healthy adult volunteers]. |
1995 |
Jpn J Antibiot |
pmid:7474332
|
Toscano MA et al. |
[Efficacy and tolerance of azithromycin in respiratory tract infections in children]. |
1995 |
Minerva Pediatr. |
pmid:7476752
|
Scheen AJ |
[Pharma-clinics. Drug of the month. Azithromycin (Zitromax)]. |
1995 |
Rev Med Liege |
pmid:7481274
|
Nahata MC et al. |
Pharmacokinetics of azithromycin in pediatric patients with acute otitis media. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7486938
|
Tomazic J et al. |
Ex vivo effect of azithromycin in human leukocyte bactericidal functions. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7486947
|
al-Assi MT et al. |
Azithromycin triple therapy for Helicobacter pylori infection: azithromycin, tetracycline, and bismuth. |
1995 |
Am. J. Gastroenterol. |
pmid:7872278
|
Andersen SL et al. |
Activity of azithromycin as a blood schizonticide against rodent and human plasmodia in vivo. |
1995 |
Am. J. Trop. Med. Hyg. |
pmid:7872444
|
Schlossberg D |
Azithromycin and clarithromycin. |
1995 |
Med. Clin. North Am. |
pmid:7791424
|
Weber JT and Johnson RE |
New treatments for Chlamydia trachomatis genital infection. |
1995 |
Clin. Infect. Dis. |
pmid:7795110
|
Nilsen OG |
Pharmacokinetics of macrolides. Comparison of plasma, tissue and free concentrations with special reference to roxithromycin. |
1995 |
Infection |
pmid:7782117
|
Fouda HG and Schneider RP |
Quantitative determination of the antibiotic azithromycin in human serum by high-performance liquid chromatography (HPLC)-atmospheric pressure chemical ionization mass spectrometry: correlation with a standard HPLC-electrochemical method. |
1995 |
Ther Drug Monit |
pmid:7624907
|
Goldstein EJ et al. |
Comparative in vitro activities of azithromycin, Bay y 3118, levofloxacin, sparfloxacin, and 11 other oral antimicrobial agents against 194 aerobic and anaerobic bite wound isolates. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7625795
|
Barry AL et al. |
Relative potencies of azithromycin, clarithromycin and five other orally administered antibiotics. |
1995 |
J. Antimicrob. Chemother. |
pmid:7628991
|
Stamm WE et al. |
Azithromycin for empirical treatment of the nongonococcal urethritis syndrome in men. A randomized double-blind study. |
1995 |
JAMA |
pmid:7629982
|
Schmid GP and Fontanarosa PB |
Evolving strategies for management of the nongonococcal urethritis syndrome. |
1995 |
JAMA |
pmid:7629989
|
Sadiq ST et al. |
Effects of azithromycin on malariometric indices in The Gambia. |
1995 |
Lancet |
pmid:7564674
|
Wawer MJ et al. |
AIDS intervention in Uganda. |
1995 |
Science |
pmid:7570005
|
Worm AM and Osterlind A |
Azithromycin levels in cervical mucus and plasma after a single 1.0g oral dose for chlamydial cervicitis. |
1995 |
Genitourin Med |
pmid:7590717
|
Gastearena I et al. |
Determination of the alpha1-acid glycoprotein binding of azithromycin in vitro by equilibrium dialysis. |
1995 |
J Chemother |
pmid:8904095
|
Domingo S et al. |
Significance of environmental conditions (pH and serum) on the in vitro potency of azithromycin against Brucella melitensis. |
1995 |
J Chemother |
pmid:8904096
|
Van Asselt GJ et al. |
Susceptibility of Streptococcus pyogenes to azithromycin, clarithromycin, erythromycin and roxithromycin in vitro. |
1995 |
J. Med. Microbiol. |
pmid:7563004
|